ECJ: centres of excellence must be available to EU citizens:
This article was originally published in Clinica
EU member states must bear the costs of treatment for their citizens when in another member state, even if the other member state treating the patient decides that the patient needs treatment in a third, non-member country. That is the conclusion reached by the European Court of Justice on April 12 2005, in case C145/03. This has significant implications for patients needing to have access to the latest treatments or medical technologies that may only be available in a few countries and not in the EU. In this case the patient, a Spanish resident, had a malignant tumour liable to cause imminent death which doctors in Germany decided could only be treated with a real chance of success in the Zurich University Clinic in Switzerland, not an EU member. "It is of no importance that the state to which the doctors have decided to transfer the patient is not a member of the EU", the ECJ concluded.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.